$REGN Buy signal in Regeneron PharmaEntry level $345 = Target price $375 = Stop loss $336
Bullish reversal occurring in regenerson after quite a sustained correction.
Historical buy signal is complete on the weekly chart, the daily chart is a little overbought so we await a break in the weekly RSI for a safer entry.
Average analysts price target $383 | Overweight.
P/E ratio 18.78.
Company profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
